News

DFS at 24 months improved from 79% with observation to 96% with the use of a 14-gene assay to guide decision making about ...
The death of a patient in a trial of an experimental gene therapy casts new shadows over a technology once seen as the future ...
A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...
Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...
A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...
Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...
Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...
Explore the evolving landscape of cell and gene therapies (CGTs) in gastroenterology. Key therapies include Anterogen's Cupistem and Takeda's Alofisel, the latter recently withdrawn by EMA. Understand ...
PL logistics need to invest in new technology and upskilling programs to scale their cell and gene therapy services.
Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...
Greater numbers of circulating stem cells increase the efficacy of in vivo gene therapy techniques, potentially reducing the price tag of lifesaving treatments.
Cancer thrives by stealing nutrients. Tumors grow fast because they hijack the body’s resources—especially glucose and fatty ...